Avita Medical (ASX: AVH)


Avita Medical (ASX: AVH) is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. www.avitamedical.com

Avita Medical ASX AVH pediatric scald RECELL system burns

Avita Medical enrols first patients in studies evaluating RECELL system

Regenerative medicine company Avita Medical (ASX: AVH) has commenced what it calls a “pivotal trial” for the treatment of paediatric scald injur...
AVITA Medical ASX AVH study results RECELL System

AVITA Medical publishes favourable study results for its RECELL System

Regenerative medicine company AVITA Medical (ASX: AVH) has published “favourable” results from an open-label feasibility study of its RECELL Aut...
AVITA Medical ASX AVH regenerative burn treatment FDA approval

AVITA Medical prepares to launch its regenerative burn treatment in the US

Just over a month since its burns treatment system was approved for FDA’s compassionate use Investigational Device Exemption (IDE) program, rege...
AVITA Medical ASX AVH FDA compassionate use expanded access RECELL device

AVITA Medical receives FDA boost for compassionate use of RECELL device

Medical device maker AVITA Medical (ASX: AVH) has received good news this morning after the US Food and Drug Administration (FDA) said it had ap...
Avita Medical ASX AVH skin regeneration Recell

Avita Medical grafts towards next generation of skin regeneration

Skin regeneration is on course for an overhaul on the back of revelations made by regenerative medicine company Avita Medical (ASX: AVH) with a ...
Avita Medical ASX AVH recell China skin regeneration

Regenerative commercial potential on the horizon for Avita Medical

A new and potentially cost-saving method of treating second-degree burns developed by Avita Medical (ASX: AVH) is now undergoing a clinical tria...
Avita Medical AVH FDA approval ReCell skin regeneration device supplement

Avita Medical gets FDA approval for ReCell skin regeneration device supplement

Avita Medical (ASX: AVH) has gained FDA approval for a new continued access protocol for its ReCell autologous cell harvesting device, which sim...